June 2021

June 2021

Welcome to the June issue of The Ophthalmologist! Our Upfront section features the latest industry and research, from what a color-blind octopus have in common with treating age-related macular degeneration to the life and times of pioneering researcher, Koji Nakanishi. In our opinion column, In My View, legendary ocular oncologist Carol Shields explains why passing knowledge and good practices to new generations of ophthalmologists is vital – spoiler: it gives teachers a real sense of achievement and improves patient care. For our cover feature, “Dry Eye Debate: The Progressive Practice,” four experts Elizabeth Yeu, Laura Periman, Stefano Barabino, and William Trattler explore the issues affecting ocular surface disease treatment. The issue’s In Practice articles take on what all ophthalmologists need to know about two conditions they will probably never see: Stevens-Johnson syndrome and toxic epidermal necrolysis; four common misconceptions about later-stage cross-linking for progressive keratoconus; and the European Glaucoma Society Guidelines Committee latest recommendations for the initial open angle glaucoma treatment. In NextGen, Stylianos Michalakis looks at novel gene vectors delivered by intravitreal rather than subretinal injection and why they represent a lower-risk option for retinal dystrophy patients. We also look at the VISION LINKS 2020 program, building long-term and long-distance ophthalmic partnerships to share knowledge, enhance education, and improve patient care worldwide; share a tale of the twin sisters breaking barriers to save sight in rural India; and learn the secrets to a successful contract negotiation – as according to doctor, lawyer, and founder of MDNegotiation, Lisa Nijm. Finally, we sit down with Erin Shriver, Clinical Professor, Oculoplastic, Orbital and Oncology Service, University of Iowa Hospitals and Clinics, Iowa City, USA. I hope you enjoy reading this issue!